ArticleMolecular neurobiology2025
Cellular Distribution of Pyruvate Kinase M2 After Spinal Cord Injury in Adult Rats.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Pyruvate kinases are key enzymes of glycolytic metabolism of neurons and glia. One of them, pyruvate kinase M2 (PKM2) can also act as a transcriptional regulator and in this function has been implicated in several neurodegenerative diseases. Since nuclear translocation of PKM2 induces the expression of inflammatory genes in macrophages, we hypothesized that this mechanism contributes to the neurodegenerative processes after spinal cord injury (SCI). Using a rat model of contusion SCI, quantitative RT-PCR showed a strong upregulation of PKM2 transcripts close to the lesion center. To understand the functional implication of this observation, we studied PKM2 antigen expression in different cell types. Spinal cord injury caused a significant increase of PKM2 immunoreactivity in microglia, astrocytes and motor neurons but not in interneurons and oligodendrocytes. Phagocytes were strongly PKM2-positive and displayed a marked accumulation of PKM2 in the lesion core, suggesting its involvement in the inflammatory and phagocytosis response. The expression in astrocytes increased notably in the chronic phase surrounding the lesion site, coinciding with formation of the glial scar. An analysis of the intracellular distribution revealed that microglia in various states of activation, macrophages, astrocytes and oligodendrocytes contained PKM2 in both the cytosol and nucleus. Contrary to our hypothesis, SCI did not induce a significant nuclear translocation of PKM2 in any of these cell types. Our data stress the importance of PKM2 in the CNS and its implication after traumatic injury.
Indexed as
Identifiers
41317245What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.